News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
216,895 Results
Type
Article (18137)
Company Profile (159)
Press Release (198599)
Section
Business (61620)
Career Advice (194)
Deals (8976)
Drug Delivery (50)
Drug Development (33870)
Employer Resources (33)
FDA (6725)
Job Trends (6238)
News (111925)
Policy (11300)
Tag
Academia (1568)
Alliances (17592)
Alzheimer's disease (517)
Approvals (6698)
Artificial intelligence (67)
Bankruptcy (51)
Best Places to Work (5866)
Biosimilars (38)
Biotechnology (119)
Breast cancer (57)
Cancer (464)
Cardiovascular disease (42)
Career advice (175)
CAR-T (36)
Cell therapy (107)
Clinical research (27331)
Collaboration (178)
Compensation (69)
COVID-19 (1054)
C-suite (50)
Cystic fibrosis (42)
Data (549)
Diabetes (74)
Diagnostics (2104)
Drug pricing (47)
Earnings (18172)
Events (31873)
Executive appointments (130)
FDA (6956)
Featured Employer (36)
Funding (121)
Gene editing (47)
Gene therapy (97)
GLP-1 (320)
Government (1562)
Healthcare (7588)
Infectious disease (1093)
Inflammatory bowel disease (74)
IPO (4283)
Job creations (716)
Job search strategy (167)
Layoffs (116)
Legal (1779)
Lung cancer (74)
Manufacturing (72)
Medical device (2522)
Medtech (2523)
Mergers & acquisitions (4753)
Metabolic disorders (212)
Neuroscience (627)
NextGen Class of 2024 (2121)
Non-profit (1684)
Northern California (616)
Obesity (138)
Opinion (62)
People (21762)
Phase I (7537)
Phase II (11039)
Phase III (10711)
Pipeline (162)
Postmarket research (1433)
Preclinical (3007)
Radiopharmaceuticals (137)
Rare diseases (107)
Real estate (1530)
Regulatory (8555)
Research institute (1336)
Southern California (479)
Startups (1351)
United States (5257)
Vaccines (228)
Weight loss (89)
Date
Today (93)
Last 7 days (447)
Last 30 days (1433)
Last 365 days (15615)
2024 (13633)
2023 (16755)
2022 (20917)
2021 (21715)
2020 (19867)
2019 (17103)
2018 (12832)
2017 (12035)
2016 (11195)
2015 (12067)
2014 (8452)
2013 (6942)
2012 (7035)
2011 (7000)
2010 (5671)
Location
Africa (232)
Asia (14636)
Australia (2047)
California (1275)
Canada (371)
China (108)
Colorado (47)
Connecticut (70)
Delaware (41)
Europe (32563)
Florida (178)
Illinois (125)
Indiana (110)
Japan (43)
Maryland (178)
Massachusetts (1173)
Minnesota (44)
New Jersey (473)
New York (378)
North Carolina (325)
Northern California (616)
Ohio (53)
Pennsylvania (293)
South America (293)
Southern California (479)
Texas (120)
Utah (39)
Washington State (177)
216,895 Results for "scipher medicine".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Dr. Reginald Seeto Appointed as CEO and President, to Lead Scipher Medicine’s Next Phase of Growth
Scipher Medicine, an AI-enabled precision immunology company, today announced the appointment of Reginald Seeto, MBBS*, as Chief Executive Officer and President.
May 9, 2024
·
5 min read
Business
Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis
Quest Diagnostics and Scipher Medicine, today announced a multi-pronged collaboration designed to expand patient access to diagnostic services advancing precision medicine for rheumatoid arthritis (RA).
November 28, 2023
·
6 min read
Business
Scipher Medicine Signs Multi-Target Partnership with Ionis
Scipher Medicine announced that it has entered into a multi-disease area collaboration with Ionis Pharmaceuticals.
July 17, 2023
·
2 min read
Genetown
Scipher Medicine Receives Medicare Coverage for PrismRA® Test in Rheumatoid Arthritis Patients
Scipher Medicine Corporation today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC), and Centers for Medicare and Medicaid Services (CMS) published a local coverage determination (LCD) for molecular biomarker testing to guide targeted therapy selection in rheumatoid arthritis (RA) patients.
September 7, 2023
·
2 min read
Genetown
Scipher Medicine Announces Publication of Positive Results From AIMS Clinical Study
Scipher Medicine announced data validating the clinical utility of the company’s PrismRA test for guiding treatment selection for rheumatoid arthritis (RA) patients.
November 10, 2022
·
3 min read
Genetown
Galapagos In-licenses Novel Drug Targets for Inflammatory Bowel Disease Discovered by Scipher Medicine’s Spectra™ Platform
Scipher Medicine today announced that Galapagos (Euronext & NASDAQ: GLPG) has exercised its option to in-license novel drug targets for inflammatory bowel disease (IBD) discovered by Scipher’s Spectra™ platform.
May 24, 2022
·
2 min read
Genetown
Scipher Medicine Closes $110 Million Financing
Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, announced the completion of a $110 million financing.
February 24, 2022
·
3 min read
Business
TARA Biosystems Partners with Scipher Medicine®
TARA Biosystems Partners with Scipher Medicine ®
November 3, 2021
·
5 min read
Genetown
Scipher Medicine® to Present at the Jeffries London Healthcare Conference
Scipher Medicine ® to Present at the Jeffries London Healthcare Conference
November 11, 2021
·
1 min read
Business
Scipher Medicine Appoints Richard Blackburn to its Advisory Board
Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, announced the appointment of Richard Blackburn to its advisory board.
December 16, 2021
·
2 min read
1 of 21,690
Next
